SureTrader Nadex Advertisement Interactive Brokers Advertisement SureTrader
Home > Boards > US Listed > Medical - Drugs > Nektar Therapeutics (NKTR)

Bad link... try this one for AMLN [#msg-10433899]

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
SeriousMoney Member Profile
 
Followed By 30
Posts 7,965
Boards Moderated 5
Alias Born 04/05/05
160x600 placeholder
New Research Collaboration between Nektar and Takeda to Explore Combination Cancer Therapy Approaches with NKTR-214, a CD122-... "PR Newswire (US)" - 5/22/2017 9:00:00 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 5/19/2017 4:32:42 PM
Nektar Therapeutics Announces Data Presentations at ASCO 2017 "PR Newswire (US)" - 5/18/2017 8:00:00 AM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 5/17/2017 6:03:40 PM
Specialized Disclosure Report (sd) "Edgar (US Regulatory)" - 5/15/2017 5:22:50 PM
Nektar to Webcast Presentation at UBS Global Healthcare Conference 2017 in New York "PR Newswire (US)" - 5/15/2017 4:15:00 PM
Quarterly Report (10-q) "Edgar (US Regulatory)" - 5/10/2017 6:11:00 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 5/9/2017 4:34:25 PM
Nektar Therapeutics Reports Financial Results for the First Quarter of 2017 "PR Newswire (US)" - 5/9/2017 4:10:00 PM
Nektar Appoints Brian L. Kotzin, M.D. as Head of Clinical Development for Nektar's Immunology Program "PR Newswire (US)" - 5/3/2017 9:15:00 AM
Nektar to Announce Financial Results for the First Quarter of 2017 on Tuesday, May 9, 2017, After Close of U.S.-Based Financi... "PR Newswire (US)" - 5/2/2017 9:15:00 AM
Additional Proxy Soliciting Materials (definitive) (defa14a) "Edgar (US Regulatory)" - 5/1/2017 3:43:31 PM
Proxy Statement (definitive) (def 14a) "Edgar (US Regulatory)" - 5/1/2017 3:37:45 PM
Nektar Therapeutics to Host Analyst & Investor Event at 2017 ASCO Annual Meeting "PR Newswire (US)" - 4/20/2017 9:10:00 AM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 4/19/2017 7:32:16 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 4/11/2017 6:06:12 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 4/7/2017 6:08:35 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 4/7/2017 6:07:13 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 4/7/2017 6:02:30 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 4/5/2017 5:17:06 PM
Nektar Therapeutics Presents New Preclinical Data for its Immuno-Oncology Programs at the American Association for Cancer Res... "PR Newswire (US)" - 4/4/2017 9:00:00 AM
Nektar Therapeutics Initiates Clinical Study of NKTR-358, a First-in-Class Regulatory T Cell Stimulator, Being Developed for ... "PR Newswire (US)" - 3/27/2017 9:00:00 AM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 3/22/2017 6:05:07 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 3/20/2017 7:38:16 AM
NKTR-181 Meets Primary and Secondary Endpoints in Phase 3 SUMMIT-07 Study in Chronic Pain "PR Newswire (US)" - 3/20/2017 7:30:00 AM
SeriousMoney   Friday, 03/31/06 07:48:21 PM
Re: bernoulli post# 31
Post # of 166 
Bad link... try this one for AMLN [#msg-10433899]




"Growth is all that matters!" CRAMER
SureTrader
Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist